Peptide Technologies vs Shanghai JinBei Chemical
Independent side-by-side comparison across the 0 peptides both vendors sell. Composite scores, lab quality, and verified pricing.
Peptide Technologies
5 BPC-157 tests with score variance 5.0–10.0. GHK-Cu and Ipamorelin coverage solid.
Peptide Technologies full review →Shanghai JinBei Chemical
Manufacturer with focus on Tirzepatide. 9 tests averaging 8.6/10. Less Western community sentiment.
Shanghai JinBei Chemical full review →Side-by-side breakdown
| PEPTIDE | PEPTIDE TECHNOLOGIES | SHANGHAI JINBEI CHEMICAL | WINNER |
|---|---|---|---|
| GHK-Cu |
7.4
B (6 tests)
|
—(not sold)
|
Peptide Technologies only |
| BPC-157 |
6.5
B (5 tests)
|
—(not sold)
|
Peptide Technologies only |
| Tirzepatide |
—(not sold)
|
8.6
B+ (9 tests)
|
Shanghai JinBei Chemical only |
| Semaglutide |
—(not sold)
|
7.5
B (8 tests)
|
Shanghai JinBei Chemical only |
Which to choose
Across the 0 peptides both vendors sell, Peptide Technologies scores higher on 0, Shanghai JinBei Chemical scores higher on 0, and 0 are within 0.3 points (effectively tied). Shanghai JinBei Chemical additionally sells Tirzepatide, Semaglutide; Peptide Technologies does not. Peptide Technologies additionally sells GHK-Cu, BPC-157; Shanghai JinBei Chemical does not.
Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.
Full profiles: Peptide Technologies review · Shanghai JinBei Chemical review